Pathogenesis of Acute Coronary Syndromes Nathan Wong

Slides:



Advertisements
Similar presentations
MRI and MRA of the Carotid Arteries
Advertisements

Statins as Protective Agents for Aortic Endothelial Cells Robert Kreisberg West Liberty State College.
Atherosclerosis Mike Clark, M.D.. Terms Arteriosclerosis – hardening of the arteries Atherosclerosis – a form of arteriosclerosis Venosclerosis Arteriolosclerosis.
Atherosclerosis.
Pathogenesis of Atherosclerosis Judith Berliner, Ph.D. Departments of Pathology and Medicine Division of Cardiology David Geffen School of Medicine at.
Stents Are Not Enough: Statins Keith Channon Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford.
PBL CV 2 Pathophysiology of coronary artery disease.
ATHEROSCLEROSIS Sufia Husain. Pathology. KSU. Riyadh. March 2015
Anatomo-Histology From Table 8.10 Brain atrophy, flattening of gyri,
Aging of the Cardiovascular System (continued)
Extracellular cholesterol and cholesterol-filled macrophages (foam cells) accumulate in subendothelial space. Subsequent structural modifications of LDL.
ATHEROSCLEROSIS By Joshua Bower Easter Revision 2014
Types of blood vessels: Veins Arteries Common structures Tunica adventitia Tunica media Tunica intima Lumen.
PATHOLOGY OF VASCULAR OCCLUSION, ATHEROSCLEROSIS, HYPERTENSION AND LYMPHEDEMA.
ATHEROSCLEROSIS Dr. Gehan Mohamed Dr. Abdelaty Shawky.
ATHEROSCLEROSIS Dr. Gehan mohamed
Atherosclerosis  hardening of the arteries due to the deposition of atheromas  heart disease is the leading cause of death  caused by the deposition.
2001: This is the beginning of the new theory!. Inflammation and Atherosclerosis, Libby, Ridker, Maseri, Circ., 2001, 105,
Lipoprotein Structures, Function and Metabolism (4)
The Biology of Atherosclerosis, Heart Attacks and Strokes
Atherosclerosis Hisham Al Khalidi. Vessel wall structure.
Atherosclerosis.
Ischaemic Heart Disease (Coronary Artery Disease)
Atherosclerosis Jana Novotná.
03/06/231 K June /06/232 Atherosclerosis Etiology Classic Risk Factors Dyslipidemia Low HDL Epidemiological Studies (e.g. Framingham) Genetic.
ATHEROSCLEROSIS Dr: Wael H.Mansy, MD Assistant Professor
Associate professor of pathology
Atherosclerosis CVS lecture 2 Atherosclerosis Shaesta Naseem.
Atherosclerosis CVS 1 Hisham Al Khalidi. Atherosclerosis.wmv.
Inflammation and atherosclerosis Immune cells dominate early lesions Immune effector molecules accelerate lesion progression Activation of inflammation.
atherosclerosis Jon Yap John A. Burns School of Medicine
Atherosclerosis CVS lecture 2 Atherosclerosis. Vessel wall structure.
ATHEROSCLEROSIS Dr. Gehan Mohamed Dr. Abdelaty Shawky.
Dr.Hesham Rashid, MD PATHOGENIC MECHANISMS OF ATHEROSCLEROSIS
ATHEROSCLEROSIS DR.SAMINA QAMAR ASSISTANT PROFESSOR HISTOPATHOLOGY.
Pathology of Atherosclerosis
VASCULAR DISEASE Atherosclerosis Jagdish Butany,MBBS,MS,FRCPC, Prof. Dept Lab Med & Pathobiol., Pathologist, UHN-Toronto Gen/Hosp
Atherosclerosis Please read Robbins p
순환기질환 - 혈관, 림프관 -.
HANDBOOK OF DYSLIPIDEMIA AND ATHEROSCLEROSIS Part One Professor Jean-Charles Fruchart Department of Atherosclerosis (Inserm UR545) Pasteur Institute of.
1 Atherosclerosis ISCHEMIC CHEART DISEASE. 2 Atherosclerosis ATHEROSCLEROSIS IS THE CHRONIC DISEASE WITH THE LIPID AND PROTEIN ABNORMAL METABOLISMS, WITH.
ATHEROSCLEROSIS.
Atherosclerosis. Atheroma are not merely filled with lipid, but contain cells whose functions critically influence atherogenesis: Intrinsic Vascular Wall.
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: Pharmacologic plaque passivation for the reduction.
Is atherosclerosis a metabolic disease?
Peter Libby, MD  The American Journal of Medicine 
Should we Use OCT in STEMI Patients?
Once adherent, some white blood cells migrate into the intima
Plaque rupture, thrombosis, and healing. A
HDL and Atherosclerosis
TRAF5 Deficiency Accelerates Atherogenesis in Mice by Increasing Inflammatory Cell Recruitment and Foam Cell FormationNovelty and Significance by Anna.
B: Basic science update: Molecular mechanisms of atherosclerosis
Understanding Acute Coronary Syndromes
B. Mechanisms of disease
Section I: RAS manipulation
Advanced Nutrition Diet and Cardiovascular Disease 1
HDL and Atherosclerosis
N Pathophys ACS 1/11/2019 2:12:25 AM Slide 1
Atheroma: more than mush
Chapter 12 Pathophysiology of Atherosclerosis
Nat. Rev. Cardiol. doi: /nrcardio
Arterial wall: structure and function
Section 4: Plaque dynamics and stenosis
Diabetes and atherosclerosis
Lipid core constitution Activated macrophages accumulate lipids
Atherosclerosis Dr:HAMED ALGHAMDI.
The Biological Role of Inflammation in Atherosclerosis
Impaired Lung Function and Risk for Stroke
Atherosclerosis  Christopher K. Glass, Joseph L. Witztum  Cell 
The Pathology of Atherosclerosis: Plaque Development and Plaque Responses to Medical Treatment William Insull, Jr, MD Professor of Medicine and Pediatrics,
Presentation transcript:

Pathogenesis of Acute Coronary Syndromes Nathan Wong BIOGRAPHICAL SKETCH(../lec5081/sketch.htm)

Schematic Time Course of Human Atherogenesis Ischemic Heart Disease Cerebrovascular Disease Peripheral Vascular Disease BIOGRAPHICAL SKETCH(../lec5081/sketch.htm) Transition from chronic to acute atheroma

Atherosclerosis: A Progressive Process Plaque Rupture/ Fissure & Thrombosis Occlusive Atherosclerotic Plaque Fatty Streak Fibrous Plaque Unstable Angina Normal MI Coronary Death Stroke Effort Angina Claudication Clinically Silent Critical Leg Ischemia Increasing Age Courtesy of P Ganz.

The Anatomy of Atherosclerotic Plaque Intima Lipid core Fibrous cap Lumen Media – T lymphocyte – Macrophage foam cell (tissue factor+) – “Activated” intimal SMC (HLA-DR+) – Normal medial SMC Libby P. Lancet. 1996;348:S4-S7.

Angiographically Inapparent Atheroma Nissen et al. In: Topol. Interventional Cardiology Update. 14;1995.

The Matrix Skeleton of Unstable Coronary Artery Plaque Fissures in the fibrous cap Davies MJ. Circulation. 1996;94:2013-2020.

Characteristics of Plaques Prone to Rupture Fibrous cap Media Lumen Lipid core area of detail “Vulnerable” plaque Lumen – T lymphocyte – Macrophage foam cell (tissue factor+) Lipid core – “Activated” intimal SMC (HLA-DR+) – Normal medial SMC “Stable” plaque Libby P. Circulation. 1995;91:2844-2850.

Proposed Mechanisms of Event Reduction by Lipid-Lowering Therapy Improved endothelium-dependent vasodilation Stabilization of atherosclerotic lesions especially nonobstructive, vulnerable plaques Reduction in inflammatory stimuli lipoproteins and modified lipoproteins Prevention, slowed progression, or regression of atherosclerotic lesions Libby P. Circulation. 1995;91:2844-2850.

Atheroma are not merely filled with lipid, but contain cells whose functions critically influence atherogenesis: Intrinsic Vascular Wall Cells: Endothelium Smooth Muscle Cells Inflammatory Cells: Macrophages T Lymphocytes Mast Cells

Cell Types in the Human Atheroma Monocyte/ Macrophage Intima Endothelium Tunica Media T-lymphocytes Smooth muscle cells

Schematic Time Course of Human Atherogenesis Ischemic Heart Disease Cerebrovascular Disease Peripheral Vascular Disease Lesion initiation No symptoms + Symptoms Symptoms Time (y)

Macrophage Functions in Atherogenesis Attachment

Leukocyte–Endothelial Adhesion Molecules Mono T PMN B

Vascular Cell Adhesion Molecule 1 (VCAM-1) Binds monocytes and lymphocytes - Cells found in atheroma Expressed by endothelium over nascent fatty streaks Expressed by microvessels of the mature atheroma

An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium Li H et al. Arterioscler Thromb 1993;13:197-204.

VCAM-1 Expression in Rabbit Aorta 3 weeks on atherogenic diet Li H et al. Arterioscler Thromb 1993;13:197-204.

Macrophage Functions in Atherogenesis Penetration

Monocyte Chemoattractant Protein 1 (MCP-1) A potent mononuclear cell chemoattractant Produced by endothelial and smooth muscle cells Localizes in human and experimental atheroma

Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low-density lipoprotein receptor–deficient mice Gu L et al. Mol Cell 1998;2:275-281.

Reduced Lipid Deposition in MCP-1–Deficient Atherosclerotic Mice LDL-R –/– MCP-1 +/+ LDL-R –/– MCP-1 –/– Gu L et al. Mol Cell 1998;2:275-281.

Reduced Lipid Deposition in MCP-1–Deficient Atherosclerotic Mice % Aortic Surface Stained Oil Red Staining ** * Gu L et al. Mol Cell 1998;2:275-281. +/+ -/- +/+ -/- Time on Diet: 12 – 14 weeks 20 – 25 weeks *P = 0.001 compared to +/+ **p = 0.005 compared to +/+

Macrophage Functions in Atherogenesis Division

Molecular Mediators of Atherogenesis VCAM-1 MCP-1 M-CSF

Matrix Metabolism and Integrity of the Plaque’s Fibrous Cap Synthesis Breakdown Collagen-degrading Proteinases Fibrous cap IFN- – CD-40L + + + + IL-1 TNF- MCP-1 M-CSF + + Lipid core Tissue Factor Procoagulant Libby P. Circulation 1995;91:2844-2850.

Increased Expression of Interstitial Collagenase (CL) by Smooth Muscle Cells (SMC) and Macrophages (M) in Human Atheroma Galis ZS et al. J Clin Invest 1994;94:2493-2503.

Plaque Rupture with Thrombosis Fibrous cap Thrombus 1 mm Lipid core Illustration courtesy of Frederick J. Schoen, M.D., Ph.D.

Thrombosis of a Disrupted Atheroma, the Cause of Most Acute Coronary Syndromes, Results from: Weakening of the fibrous cap Thrombogenicity of the lipid core Illustration courtesy of Michael J. Davies, M.D.